Transformative Solutions to Streamline Development of Novel Radiopharmaceuticals

Bringing new imaging and therapeutic radiopharmaceuticals to the market is a complex and challenging process that requires strong non-clinical data to support Investigational New Drug (IND) and Clinical Trial Application (CTA).

Preclinical radiopharmaceutical development requires specific studies including:

  • Primary Pharmacology 
  • Safety Pharmacology and Toxicology
  • Radiochemistry and Immunoreactivity
  • Animal Biodistribution and Dosimetry

Learn more about the importance of specific non-clinical studies that help streamline the development of your novel radiopharmaceutical by downloading the infographic.